Development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria
Mark Charbonneau et al. develop a mathematical model that describes the behavior of an engineered bacterial therapeutic, SYNB1618, in the human gastrointestinal tract and its effects on plasma phenylalanine (Phe) levels. This model enables the authors to predict plasma Phe lowering by SYNB1618 in pa...
Guardado en:
Autores principales: | Mark R. Charbonneau, William S. Denney, Nicholas G. Horvath, Pasquale Cantarella, Mary J. Castillo, Marja K. Puurunen, Aoife M. Brennan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9c842b6d19dd4ea5ab162237138ababd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Characterization of an engineered live bacterial therapeutic for the treatment of phenylketonuria in a human gut-on-a-chip
por: M. Tyler Nelson, et al.
Publicado: (2021) -
Population pharmacokinetics of olprinone in healthy male volunteers
por: Kunisawa T, et al.
Publicado: (2014) -
Pulmonary function with expiratory resistive loading in healthy volunteers.
por: Jyotika Erram, et al.
Publicado: (2021) -
Increased set shifting costs in fasted healthy volunteers.
por: Heather M Bolton, et al.
Publicado: (2014) -
ASSESSING EFFECTS OF CUCURBITURILS ON MONOCYTES AND NK-CELLS IN HEALTHY VOLUNTEERS
por: A. A. Aktanova, et al.
Publicado: (2021)